Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.

 
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Pharmaceutical Executive Europe E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma leaders, what do you see as the chief obstacle to growth in the emerging markets?

Patent issues 46%
Counterfeiting 21%
Safety 13%
Manufacturing 5%
R&D 15%

Talk to us:
editor@pharmexeceurope.com

Advertise with us: jgray@advanstar.com

13 March, 2012
In this Issue
Novartis: To LEAD in the BRIC Economies
With growth as its guiding light, Novartis has big plans for the emerging markets. CEO Joe Jimenez tells Pharm Exec how the company's LEAD program will help it beat the competition. More...
Why Europe Needs to Step Up the Fight Against Counterfeiting
Traditionally more prevalent in less industrialized regions, counterfeit medicines are now more frequently entering the heavily regulated supply chains of EU countries, writes Nathan Jessop. More...
Podcast: Clinical Trials in China — Lessons for the Smaller Pharma Company
R. Stephen Porter of VDDI Pharmaceuticals and Dragon Bio-Consultants shares his expertise on conducting clinical trials in China in this exclusive podcast. More...
Train Your Staff without a Classroom
Mark McClelland and Candida Chandorkar outline how organizations sector can improve their continuing professional development and effectiveness at work without the need of a classroom environment. More...
Also in this issue…
FDA Issues Guidance Agenda for 2012
BI Expands Biomanufacturing Capacity in Europe
WHO Joins Expanding International GMP Collaboration
Case Study
Reducing outsourcing costs and cycle-times
Discover how a biotech saved $600,000 on a Phase II contract, compressed the contracting cycle-time from three months to two weeks, and formed a more constructive and collaborative working relationship with their CRO.
Download the case study today.
Product Profile
GxP Cloud now with SaaS
With validated GxP applications ready as SaaS in NNIT's GxP Cloud you can save deployment and validation costs as well as time. Read more

Event Profile
"The pharma sales force is a shambles…" according to one Top-10-pharma SFE Director. With the theme of 'customer evolution, pharma revolution'. The world's largest commercial pharma event 'SFE Europe' has locked down its focus. See why 1000 people will be celebrating SFE's 10th birthday

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK